A phase I study to investigate the absorption, metabolism and excretion of [14C]-bilastine following oral administration to healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 13 Dec 2018
At a glance
- Drugs Bilastine (Primary)
- Indications Allergic conjunctivitis; Perennial allergic rhinitis; Seasonal allergic rhinitis; Urticaria
- Focus Pharmacokinetics
- Sponsors FAES Farma
- 09 Jan 2009 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
- 09 Jan 2009 Actual start date changed from Dec 2007 to Nov 2007 as reported by ClinicalTrials.gov.
- 09 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.